U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07828860) titled 'Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa' on Sept. 03.
Brief Summary: Safety and Efficacy of Soquelitinib in Adults with Hidradenitis Suppurativa
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Hidradenitis Suppurativa (HS)
Intervention:
DRUG: Soquelitinib
Tablets
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Corvus Pharmaceuticals, Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....